Patents by Inventor Jeffrey Richard Jackson

Jeffrey Richard Jackson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human pelota homolog
    Publication number: 20040096888
    Abstract: 68772 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing 68772 polypeptides and polynucleotides in the design of protocols for the treatment of proliferative diseases such as leukemias, solid tumor cancers and metastases; chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis; proliferative cardiovascular diseases such as restenosis; prolifertive ocular disorders such as diabetic retinopathy; and benign hyperproliferative diseases such as hemangiomas, among others, and diagnostic assays for such conditions.
    Type: Application
    Filed: October 6, 2003
    Publication date: May 20, 2004
    Applicant: SmithKline Beecham Corp.
    Inventors: Jeffrey Richard Jackson, Michael Joseph Hansbury
  • Human Pelota homolog
    Patent number: 6657047
    Abstract: 68772 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing 68772 polypeptides and polynucleotides in the design of protocols for the treatment of proliferative diseases such as leukemias, solid tumor cancers and metastases; chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis proliferative cardiovascular diseases such as restenosis; prolifertive ocular disorders such as diabetic retinopathy; and benign hyperproliferative diseases such as hemangiomas, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: December 2, 2003
    Assignee: SmithKline Beecham Corporation
    Inventors: Jeffrey Richard Jackson, Michael Joseph Hansbury
  • Human pelota homolog
    Publication number: 20020164734
    Abstract: 68772 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing 68772 polypeptides and polynucleotides in the design of protocols for the treatment of proliferative diseases such as leukemias, solid tumor cancers and metastases; chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis; proliferative cardiovascular diseases such as restenosis; prolifertive ocular disorders such as diabetic retinopathy; and benign hyperproliferative diseases such as hemangiomas, among others, and diagnostic assays for such conditions.
    Type: Application
    Filed: December 21, 2001
    Publication date: November 7, 2002
    Applicant: SmithKline Beecham Corporation
    Inventors: Jeffrey Richard Jackson, Michael Joseph Hansbury
  • Human pelota homolog
    Patent number: 6342584
    Abstract: 68772 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing 68772 polypeptides and polynucleotides in the design of protocols for the treatment of proliferative diseases such as leukemias, solid tumor cancers and metastases; chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis; proliferative cardiovascular diseases such as restenosis; prolifertive ocular disorders such as diabetic retinopathy; and benign hyperproliferative diseases such as hemangiomas, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: January 29, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Jeffrey Richard Jackson, Michael Joseph Hansbury
  • Human pelota homolog
    Patent number: 5925539
    Abstract: 68772 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing 68772 polypeptides and polynucleotides in the design of protocols for the treatment of proliferative diseases such as leukemias, solid tumor cancers and metastases; chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis; proliferative cardiovascular diseases such as restenosis; prolifertive ocular disorders such as diabetic retinopathy; and benign hyperproliferative diseases such as hemangiomas, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: September 2, 1998
    Date of Patent: July 20, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: Jeffrey Richard Jackson, Michael Joseph Hansbury
  • Human disintegrin metalloprotease KUZ gene
    Patent number: 5922546
    Abstract: Human KUZ polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing Human KUZ polypeptides and polynucleotides in the design of protocols for the treatment of inflammation, neural degeneration, allergic disorders, or other disorders involving a dis-regulation of the substrate cytokines or receptors, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: August 25, 1997
    Date of Patent: July 13, 1999
    Assignee: Smithkline Beecham Corporation
    Inventors: Ruth Judik Mayer, Jeffrey Richard Jackson, Catherine Elizabeth Ellis
  • Human pelota homolog
    Patent number: 5922853
    Abstract: 68772 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing 68772 polypeptides and polynucleotides in the design of protocols for the treatment of proliferative diseases such as leukemias, solid tumor cancers and metastases; chronic inflammatory proliferative diseases such as psoriasis and rheumatoid arthritis; proliferative cardiovascular diseases such as restenosis; prolifertive ocular disorders such as diabetic retinopathy; and benign hyperproliferative diseases such as hemangiomas, among others, and diagnostic assays for such conditions.
    Type: Grant
    Filed: July 15, 1997
    Date of Patent: July 13, 1999
    Assignee: SmithKline Beecham Corporation
    Inventors: Jeffrey Richard Jackson, Michael Joseph Hansbury